Daslemia 100 mg Tablet
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Daslemia 100 mg Tablet

Daslemia 100 mg Tablet

Daslemia 100 mg Tablet contains dasatinib 100 mg and is an oral targeted anticancer medicine. It is used to treat specific types of blood cancers, including Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. The tablet is a prescription medicine and should be taken under specialist medical supervision.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that blocks BCR-ABL and other abnormal kinase proteins involved in the growth of certain leukemia cells. This targeted action helps control the proliferation of abnormal blood cells and may help manage disease progression. Regular monitoring of blood counts and clinical parameters is important because treatment may cause myelosuppression, fluid retention, bleeding, and other adverse effects. The dosage and treatment duration are individualized by the treating oncologist according to the leukemia type and treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 100 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 tablets
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Daslemia 100mg Tablet, Daslemia 100 mg Tablet, Dasatinib 100mg Tablet, Dasatinib 100 mg Tablet, Dasatinib Oral Tablet, Dasatinib 100mg Anticancer Tablet, Dasatinib Leukemia Tablet